Healthcare News
01/08/2008
Researchers examine the psychological effects of the condition.
An international Parkinson's disease research project is calling for the development of new assessment procedures to examine the condition's behavioural effects.
There is evidence which suggests the disease's psychological manifestations are major factors in patients' disabilities and quality of life deterioration, according to the ELEP project, a longitudinal study based at the Carlos III Institute of Health in Madrid.
Scientists say they hope to expand the level of knowledge about the relationship between the disease itself and its psychosocial impact.
In the study, which is set to be published in Value in Health, they have found that psychological functioning showed significant variations according to illness duration and severity but correlated with the emotional status of the individual.
Researchers from the Harvard University-affiliated Brigham and Women's Hospital, the University of Wisconsin and the University of Ottawa recently found that a gene and protein which cause Parkinson's disease are controlled by genetic mechanisms in blood cells.
They said their findings raise hope for new types of therapies which focus on the alpha-synuclein gene.
Please click here to find a care home for young persons services.
Tests to begin on Parkinson's disease drug
02/09/2010
The effectiveness of a new Parkinson's disease drug is to be examined in a new test at University College London.
Charity claims victory in Parkinson's drug campaign
23/08/2010
A drug for treatment of Parkinson's disease will be made more widely-available, following a charity campaign.
Scientists claim Parkinson's disease breakthrough
17/08/2010
The use of human stem cells in rodents has managed to reverse the symptoms of Parkinson's disease, it is claimed.
Canadian scientists create 'brain on a microchip'
16/08/2010
New technology developed in Canada will help scientists to understand how Parkinson's disease works.